Short description
Biotechnology, Neuorscience
Description
APRINOIA is a late-stage biotechnology company committed to protecting patients' brain health and changing outcomes of neurodegenerative diseases through first-in-class and best-in-class diagnostic tools and novel therapies. The company aims to bring precision medicine to neuroscience by identifying and targeting the protein aggregates of tau, alpha-synuclein and other proteins that play a critical role in the pathogenesis of many neurodegenerative diseases, such as Alzheimer's and Parkinson's Diseases. The company currently has operations in Hong Kong, Suzhou, Shanghai, Tokyo, and Boston.
Total funding
$$121212
Sign in for full access
Location
Boston, Massachusetts, United States, North America
Founded on
May 20, 2015
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Investors
No Way, Noaccessforu, Noaccess, No Way, Noaccessforu, Noaccessforu, Absolutely Noaccess, Noaccess, Uh Ohhhh
Sign in for full access
Founders
Ming-Kuei Jang